Researchers at the University of Colorado believe that a component of cannabis could help improve common skin conditions like eczema or psoriasis.
Scientists have started testing CBD for its anti-inflammatory properties. The skin is the body's largest organ. It is both what protects us from the world, while putting us in contact with it. But it is also the source of many problems for millions of people. They suffer from chronic skin conditions like eczema or psoriasis. There are over-the-counter and prescription drugs, but for some people none of them work. Researchers are now looking at CBD.
Dr. Robert Dellavalle, who heads research at the University of Colorado said:
“There is a large segment of the population who does not like using steroids, even if they are steroids applied topically to their skin. CBD could be an alternative, a natural product for them. ”
Cannabis against eczema when other treatments fail
"So when someone has tried steroids or immunomodulators that suppress the immune system for psoriasis or eczema and they are not completely cured, there is potential for this news to be used. therapy that might work differently and help them, ”Dellavalle said.
It is the anti-inflammatory properties of CBD that can help with inflammation and itching in diseases like eczema. Some products containing these compounds are already on sale. Doctors warn, however, that tests need to be done.
“Not all of these products have been verified, nor tested in controlled trials, but there is a plethora of companies that make products and they are widely available and widely used for pain, itching and more. indications. And the data on its functioning is not yet systematically collected, and we would like to do so. I believe it's an open horizon with huge potential that needs to be explored, but there are a number of regulatory hurdles that need to be overcome and that's where we are, ”Dellavalle said.
A study on Parkinson's-related skin disease
Researchers have started a clinical study. This is to examine a certain skin disease that affects some patients with Parkinson's disease.
"About half of patients with Parkinson's disease have a rash on their face called seborrheic dermatitis, and it's like dandruff on the face near the nose," Dellavalle said.
Doctors want to know if a drug containing CBD can help with the Parkinson's-related rash. There are currently 40 patients enrolled in phase one and phase two clinical trials. These tests received sponsorship from the Colorado Department of Public Health. But setting up the research was not easy.
Investigations complicated by the contradiction between local and federal legislation
“The fact that it's illegal at the federal level, but legal at the state level leads to a lot of complications for cannabis and cannabinoid research. We overcame several years of regulatory hurdles to get to work, as with Parkinson's. It's actually a test. It's random, it's controlled, it's the highest level of research to eliminate doubt, ”Dellavalle concluded.
The results of the Parkinson's study are not complete. However, researchers do know that the compounds in cannabis provide relief from pain associated with eczema and psoriasis. Doctors are simply warning that more clinical trials are needed before they can make reliable recommendations.